Thomas Stephen Basil
- SEC CIK
- 0002027962
In the past year, 3 open-market sale filings worth $2.25M and no purchases.
Current role at each company
- CLYM Climb Bio, Inc.Directoras of Sep 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.25M
- 3 filings
- Net
- −$2.25M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Thomas Stephen Basil as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2026 (view filing)4:15 PM ET | Sep 15 | 2 days | Thomas Stephen BasilDirector | SSale | −100.0K | $13.67 | −$1.37M | −17.6%468.0K after | 10b5-1 |
| Feb 27, 2026 (view filing) | Feb 25-26 | 2 days | Thomas Stephen BasilDirector | SSale | −50.0K | $7.00 | −$350.2K | −24.4%154.7K after | 2 lots10b5-1 |
| Feb 17, 2026 (view filing) | Feb 12-13 | 5 days | Thomas Stephen BasilDirector | SSale | −100.0K | $5.29 | −$528.8K | −32.8%204.7K after | 2 lots10b5-1 |